Table 1.
Demographic characteristics of survey respondents.
Fig 1.
Overall response from survey participants on timing of OAC re-initiation across 11 clinical scenarios.
ICH, intracerebral haemorrhage; DOAC, direct oral anticoagulants; IPH, intraparenchymal haemorrhage; HTN, hypertension; CHADS2, Congestive heart failure, hypertension, age (≥75), diabetes, stroke/TIA score.
Table 2.
Specialty-specific variation in oral anticoagulant re-initiation following intracranial hemorrhage.
Fig 2.
Choice of anticoagulant for re-initiation across thrombosis experts, stroke neurologists and neurosurgeons.
Fig 3.
Rates of neuro-imaging utilization for risk stratification among patients with anticoagulant-associated ICH across specialties.
Intracranial vessel imaging includes CT angiography, MR angiography or Digital Subtraction Angiography.